228 related articles for article (PubMed ID: 32779023)
21. KRAS mutation is associated with worse prognosis in stage III or high-risk stage II colon cancer patients treated with adjuvant FOLFOX.
Lee DW; Kim KJ; Han SW; Lee HJ; Rhee YY; Bae JM; Cho NY; Lee KH; Kim TY; Oh DY; Im SA; Bang YJ; Jeong SY; Park KJ; Park JG; Kang GH; Kim TY
Ann Surg Oncol; 2015 Jan; 22(1):187-94. PubMed ID: 24889488
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of perineural invasion in stages II and III colorectal cancer.
Zhou Y; Wang H; Gong H; Cao M; Zhang G; Wang Y
Pathol Res Pract; 2015 Nov; 211(11):839-44. PubMed ID: 26429129
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic performance of F-18 FDG PET/CT for prediction of KRAS mutation in colorectal cancer patients: a systematic review and meta-analysis.
Kim SJ; Pak K; Kim K
Abdom Radiol (NY); 2019 May; 44(5):1703-1711. PubMed ID: 30603881
[TBL] [Abstract][Full Text] [Related]
24. [Association of peripheral nerve invasion with clinicopathological factors and prognosis of colorectal cancer].
Han D; Wei Y; Wang X; Wang G; Chen Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):62-66. PubMed ID: 28105622
[TBL] [Abstract][Full Text] [Related]
25. A clinical-radiomics model incorporating T2-weighted and diffusion-weighted magnetic resonance images predicts the existence of lymphovascular invasion / perineural invasion in patients with colorectal cancer.
Zhang K; Ren Y; Xu S; Lu W; Xie S; Qu J; Wang X; Shen B; Pang P; Cai X; Sun J
Med Phys; 2021 Sep; 48(9):4872-4882. PubMed ID: 34042185
[TBL] [Abstract][Full Text] [Related]
26. [Establishment and validation of a predictive nomogram model for advanced gastric cancer with perineural invasion].
Liu SH; Hou XY; Zhang XX; Liu GW; Xin FJ; Wang JG; Zhang DL; Wang DS; Lu Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Nov; 23(11):1059-1066. PubMed ID: 33212554
[No Abstract] [Full Text] [Related]
27. Association Between Computed Tomographic Features and Kirsten Rat Sarcoma Viral Oncogene Mutations in Patients With Stage I Lung Adenocarcinoma and Their Prognostic Value.
Wang H; Schabath MB; Liu Y; Stringfield O; Balagurunathan Y; Heine JJ; Eschrich SA; Ye Z; Gillies RJ
Clin Lung Cancer; 2016 Jul; 17(4):271-8. PubMed ID: 26712103
[TBL] [Abstract][Full Text] [Related]
28. Radiomics and Machine Learning for prediction of two-year disease-specific mortality and KRAS mutation status in metastatic colorectal cancer.
Ricci Lara MA; Esposito MI; Aineseder M; López Grove R; Cerini MA; Verzura MA; Luna DR; Benítez SE; Spina JC
Surg Oncol; 2023 Dec; 51():101986. PubMed ID: 37729816
[TBL] [Abstract][Full Text] [Related]
29. Preoperative Prediction of Perineural Invasion and Prognosis in Gastric Cancer Based on Machine Learning through a Radiomics-Clinicopathological Nomogram.
Jia H; Li R; Liu Y; Zhan T; Li Y; Zhang J
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339364
[TBL] [Abstract][Full Text] [Related]
30. BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features.
Pai RK; Jayachandran P; Koong AC; Chang DT; Kwok S; Ma L; Arber DA; Balise RR; Tubbs RR; Shadrach B; Pai RK
Am J Surg Pathol; 2012 May; 36(5):744-52. PubMed ID: 22314188
[TBL] [Abstract][Full Text] [Related]
31. Development of a dual-energy spectral CT based nomogram for the preoperative discrimination of mutated and wild-type KRAS in patients with colorectal cancer.
Cao Y; Zhang G; Bao H; Zhang S; Zhang J; Zhao Z; Zhang W; Li W; Yan X; Zhou J
Clin Imaging; 2021 Jan; 69():205-212. PubMed ID: 32920468
[TBL] [Abstract][Full Text] [Related]
32. Perineural Invasion is a Major Prognostic and Predictive Factor of Response to Adjuvant Chemotherapy in Stage I-II Colon Cancer.
Cienfuegos JA; Martínez P; Baixauli J; Beorlegui C; Rosenstone S; Sola JJ; Rodríguez J; Hernández-Lizoáin JL
Ann Surg Oncol; 2017 Apr; 24(4):1077-1084. PubMed ID: 27624582
[TBL] [Abstract][Full Text] [Related]
33. Contrast-Enhanced CT Texture Analysis in Colon Cancer: Correlation with Genetic Markers.
Crimì F; Zanon C; Cabrelle G; Luong KD; Albertoni L; Bao QR; Borsetto M; Baratella E; Capelli G; Spolverato G; Fassan M; Pucciarelli S; Quaia E
Tomography; 2022 Aug; 8(5):2193-2201. PubMed ID: 36136880
[TBL] [Abstract][Full Text] [Related]
34. The value of
Oner AO; Budak ES; Yıldırım S; Aydın F; Sezer C
Hell J Nucl Med; 2017; 20(2):160-165. PubMed ID: 28697193
[TBL] [Abstract][Full Text] [Related]
35. Correlation between KRAS mutation and
Cho A; Jo K; Hwang SH; Lee N; Jung M; Yun M; Hwang HS
Abdom Radiol (NY); 2017 Jun; 42(6):1621-1626. PubMed ID: 28161825
[TBL] [Abstract][Full Text] [Related]
36. Preoperative assessment of grade, T stage, and lymph node involvement: machine learning-based CT texture analysis in colon cancer.
Bülbül HM; Burakgazi G; Kesimal U
Jpn J Radiol; 2024 Mar; 42(3):300-307. PubMed ID: 37874525
[TBL] [Abstract][Full Text] [Related]
37. The depth of perineural invasion is an independent prognostic factor for stage II colorectal cancer.
Chen H; Wang C; Chen Z; Huang T; Lin Y; Chen J; Zhang B; He X
BMC Cancer; 2024 Apr; 24(1):433. PubMed ID: 38589842
[TBL] [Abstract][Full Text] [Related]
38. Mutation status and prognostic value of KRAS and NRAS mutations in Moroccan colon cancer patients: A first report.
El Agy F; El Bardai S; El Otmani I; Benbrahim Z; Karim MH; Mazaz K; Benjelloun EB; Ousadden A; El Abkari M; Ibrahimi SA; Chbani L
PLoS One; 2021; 16(3):e0248522. PubMed ID: 33784337
[TBL] [Abstract][Full Text] [Related]
39. Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes.
Sinicrope FA; Shi Q; Smyrk TC; Thibodeau SN; Dienstmann R; Guinney J; Bot BM; Tejpar S; Delorenzi M; Goldberg RM; Mahoney M; Sargent DJ; Alberts SR
Gastroenterology; 2015 Jan; 148(1):88-99. PubMed ID: 25305506
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers.
de Cuba EM; Snaebjornsson P; Heideman DA; van Grieken NC; Bosch LJ; Fijneman RJ; Belt E; Bril H; Stockmann HB; Hooijberg E; Punt CJ; Koopman M; Nagtegaal ID; Coupé VH; Carvalho B; Meijer GA
Int J Cancer; 2016 Mar; 138(5):1139-45. PubMed ID: 26376292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
